NCT05738564View on ClinicalTrials.gov

Epinephrine Nebulization Prior to Nasotracheal Intubation

PHASE3CompletedINTERVENTIONAL

Enrollment

126

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

September 30, 2022

Conditions

Nasal Bleeding

Interventions

DRUG

Epinephrine Inhalation Solution

epinephrine prepared solution mixed with lidocaine (EL) Otrivin adult nasal drops 0.1Otrivin adult nasal drops 0.1%, 10 ml of 1 mg/ml; Novartis Consumer Health, UK Ltd, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK) in each nostril in the pre-induction room just before the induction of anesthesia

Trial Locations (1)

3567

Ain Shams University Hospital, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER

NCT05738564 - Epinephrine Nebulization Prior to Nasotracheal Intubation | Biotech Hunter | Biotech Hunter